You are in the accessibility menu

Please use this identifier to cite or link to this item: http://acervodigital.unesp.br/handle/11449/75108
Full metadata record
DC FieldValueLanguage
dc.contributor.authordos Santos, Fernanda Kolenyak-
dc.contributor.authorOyafuso, Marcia Helena-
dc.contributor.authorKiill, Charlene Priscila-
dc.contributor.authorDaflon-Gremião, Maria Palmira-
dc.contributor.authorChorilli, Marlus-
dc.date.accessioned2014-05-27T11:28:55Z-
dc.date.accessioned2016-10-25T18:47:24Z-
dc.date.available2014-05-27T11:28:55Z-
dc.date.available2016-10-25T18:47:24Z-
dc.date.issued2013-04-12-
dc.identifierhttp://dx.doi.org/10.2174/157341313805117857-
dc.identifier.citationCurrent Nanoscience, v. 9, n. 1, p. 159-167, 2013.-
dc.identifier.issn1573-4137-
dc.identifier.issn1875-6786-
dc.identifier.urihttp://hdl.handle.net/11449/75108-
dc.identifier.urihttp://acervodigital.unesp.br/handle/11449/75108-
dc.description.abstractThe chronic hyperproliferative diseases (CHD) include cancer, precancerous lesions and diseases of unknown etiology such as psoriasis. Various drugs have been used in the treatment of CHD, such as antiproliferative and corticosteroids in general. However, some drugs have properties that limit their effectiveness, such as low solubility in water and low penetration of the skin. Thus, the control of drug release in the skin may improve efficacy and reduce side effects of many drugs used in hyperproliferative diseases. The purpose of this study was to make a systematic review of nanotechnology-based drug delivery systems used against hyperproliferative skin diseases. © 2013 Bentham Science Publishers.en
dc.description.sponsorshipFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)-
dc.description.sponsorshipConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)-
dc.description.sponsorshipPADC (Programa de Apoio ao Desenvolvimento Cientifico)-
dc.description.sponsorshipCoordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)-
dc.format.extent159-167-
dc.language.isoeng-
dc.sourceScopus-
dc.subjectChronic hyperoproliferative diseases-
dc.subjectDrug delivery systems-
dc.subjectNanotechnology-
dc.subjectPsoriasis-
dc.subjectSkin cancer-
dc.subjectSkin diseases-
dc.subjectSkin treatment-
dc.subjectAnti-proliferative-
dc.subjectDrug delivery system-
dc.subjectDrug release-
dc.subjectSkin cancers-
dc.subjectSkin disease-
dc.subjectSolubility in waters-
dc.subjectSystematic Review-
dc.subjectDermatology-
dc.subjectDisease control-
dc.subjectDrug delivery-
dc.subjectDrug interactions-
dc.subjectDrug products-
dc.subjectDiseases-
dc.subjectaminolevulinic acid-
dc.subjectbenzopsoralen 3 ethoxy carbonyl 2h benzofuro[3,2 e] 1 benzopiran 2 one-
dc.subjectchitosan derivative-
dc.subjectclobetasol propionate-
dc.subjectcorticosteroid-
dc.subjectetretin-
dc.subjectfluorouracil-
dc.subjectglycerol behenate-
dc.subjectketoprofen-
dc.subjectmethotrexate-
dc.subjectmethoxsalen-
dc.subjectn sulfonate n,o carboxymethylchitosan-
dc.subjectnanocapsule-
dc.subjectnanocoating-
dc.subjectpaclitaxel-
dc.subjectphosphatidylcholine-
dc.subjectpodophyllotoxin-
dc.subjectpoloxamer-
dc.subjectpolymer-
dc.subjectpolymeric nanoparticle-
dc.subjectpolymethacrylic acid-
dc.subjectpsoralen derivative-
dc.subjectretinoic acid-
dc.subjectsolid lipid nanoparticle-
dc.subjectspantide-
dc.subjecttacrolimus-
dc.subjecttemoporfin-
dc.subjecttriamcinolone acetonide-
dc.subjectunclassified drug-
dc.subjectbiodegradability-
dc.subjectburning sensation-
dc.subjectcell differentiation-
dc.subjectcell viability-
dc.subjectchronic hyperproliferative disease-
dc.subjectcontact dermatitis-
dc.subjectcream-
dc.subjectdermatitis-
dc.subjectdrug absorption-
dc.subjectdrug cytotoxicity-
dc.subjectdrug delivery system-
dc.subjectdrug efficacy-
dc.subjectdrug penetration-
dc.subjectdrug release-
dc.subjectdrug retention-
dc.subjectdrug safety-
dc.subjectdrug solubility-
dc.subjectencapsulation-
dc.subjecterythema-
dc.subjecthuman-
dc.subjectinjection site pruritus-
dc.subjectiontophoresis-
dc.subjectkeratinocyte-
dc.subjectliquid crystal-
dc.subjectmicroemulsion-
dc.subjectnanomedicine-
dc.subjectnanotechnology-
dc.subjectphotochemotherapy-
dc.subjectphotodynamic therapy-
dc.subjectphotosensitivity-
dc.subjectprecancer-
dc.subjectpriority journal-
dc.subjectpsoriasis-
dc.subjectPUVA-
dc.subjectskin allergy-
dc.subjectskin cancer-
dc.subjectskin disease-
dc.subjectskin infection-
dc.subjectskin penetration-
dc.subjectskin tumor-
dc.subjectstratum corneum-
dc.subjectsystematic review-
dc.subjectT lymphocyte-
dc.subjecttopical treatment-
dc.subjectultraviolet A radiation-
dc.subjectultraviolet B radiation-
dc.titleNanotechnology-based drug delivery systems for treatment of hyperproliferative skin diseases - a reviewen
dc.typeoutro-
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)-
dc.description.affiliationSchool of Pharmaceutical Sciences Postgraduate Program in Pharmaceutical Nanotechnology São Paulo State University, Araraquara-
dc.description.affiliationSchool of Pharmaceutical Sciences Postgraduate Program in Pharmaceutical Sciences São Paulo State University, Araraquara-
dc.description.affiliationUnespSchool of Pharmaceutical Sciences Postgraduate Program in Pharmaceutical Nanotechnology São Paulo State University, Araraquara-
dc.description.affiliationUnespSchool of Pharmaceutical Sciences Postgraduate Program in Pharmaceutical Sciences São Paulo State University, Araraquara-
dc.identifier.doi10.2174/157341313805117857-
dc.identifier.wosWOS:000317836000026-
dc.rights.accessRightsAcesso restrito-
dc.relation.ispartofCurrent Nanoscience-
dc.identifier.scopus2-s2.0-84875934477-
Appears in Collections:Artigos, TCCs, Teses e Dissertações da Unesp

There are no files associated with this item.
Show simple item record Show full item record   View Statistics
 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.